1.. Introduction {#s6}
================

Alzheimer's disease (AD) is one of the most common types of dementia.\[[@B1]\] In 2015 there were more than 46 million individuals with AD in the world and, based on expected increases in life expectancy, by 2050 the number of individuals with AD will surpass 100 million.\[[@B2]\] AD has an insidious onset that makes it difficult to diagnose in the early stages. There are, moreover, no effective treatments once the disease has become clinically evident,\[[@B3]\] so early recognition, diagnosis, and preemptive treatment is one of the best potential options for delaying the development of AD. However, there is, as yet, no biomarker that can accurately identify prodromal AD.\[[@B4]\]

The visual cortex is the part of the brain that controls some of the earliest clinical manifestations of AD.\[[@B5], [@B6]\] Abnormalities in visual-related functions, such as difficulty with reading and searching for targets, depth perception disabilities, and decline of spatial contrast sensitivity, are evident in individuals in the early stages of AD.\[[@B7]\] Moreover, throughout the course of AD, the retina experiences neurodegenerative changes, including loss of retinal ganglion cells and nerve fibers, macular degeneration, and increases in optic disc cupping.\[[@B5]\] The retina and the central nervous system (CNS) are homologous during embryonic development, so the retina is the only part of the CNS that can be directly observed in living individuals. Thus, the thickness of the retinal nerve fiber layer (RNFL) may act as a window to assess ongoing changes in the CNS.\[[@B8]\]

Previous methods for measuring RNFL thickness, such as fundus photography, scanning laser ophthalmoscopy (SLO), and nerve fiber analysis (NFA), depended to some extent on subjective factors, so results tended to be unreliable between different raters. The current gold standard measurement method, optic coherence tomography (OCT), can accurately delineate the 10 layers of fiber structures in the optic nerve, and it is fast, noninvasive, and economical. In the past decade studies using OCT have generally reported that the thicknesses of the peripheral RNFL among individuals with AD and mild cognitive impairment --- which is often an early transitional state prior to dementia --- were significantly thinner than the peripheral RNFL thicknesses of age-matched normal controls.\[[@B9], [@B10], [@B11]\] But there were significant differences in results for the four different quadrants of the optic nerve. Some studies showed a significant change in the superior quadrant;\[[@B11], [@B12], [@B13], [@B14], [@B15]\] others showed significant changes in the inferior quadrant;\[[@B11], [@B14], [@B15]\] while still others showed significant changes in the temporal quadrant.\[[@B14], [@B16], [@B17]\] Moreover, there were inconsistent findings about differences of RNFL thickness between individuals with AD and those with MCI; some studies showed that individuals with AD had significantly thinner RNFL than individuals with MCI, \[[@B14], [@B17]\] but other studies did not support this finding.\[[@B11], [@B15], [@B18]\]

To clarify the relative importance of RNFL in different optic nerve quadrants and to summarize results comparing RNFL results for persons with AD versus those for persons with MCI, this systematic review and meta-analysis pools data about RNFL thickness from studies that meet rigorous inclusion criteria. The results are used to assess the potential usefulness of RNFL thickness as a biomarker for early AD.

2.. Methods {#s7}
===========

2.1. Data retrieval {#s7a}
===================

The article retrieval process is depicted in [Figure 1](#Figure1){ref-type="fig"}. English databases considered include PubMed (1977- 2015), Embase (1971-2015), ISI web of knowledge (1955-2015), Ovid/MEDLINE (1967-2015), Science Direct (1965-2015), and the Cochrane Library (1967-2015). Chinese databases considered include the Chinese National Knowledge Infrastructure (CNKI) database (1980-2015), the Chongqing VIP database for Chinese Technical Periodicals (VIP) (1996-2015), WANFANG DATA (1977-2015), and the China BioMedical Literature Service System (SinoMed) (1995-2015). The English search keywords were 'retinal', 'retinal thickness', 'retinal nerve fiber layer', 'RNFL', 'AD', 'Alzheimer disease', 'MCI', 'mild cognitive impairment', 'cognitive', 'dementia', and 'neurodegenerative disease'. The Chinese search terms included both the English terms and their Chinese equivalents. The electronic search for articles was completed before February 20, 2015.

![Figure 1. Identification of studies included in the analysis](sap-27-05-263-e001){#Figure1}

We imported identified articles into Endnote X5 and deleted the duplicates. Two authors (MW and ZS) individually read the remaining article titles and abstracts in order to filter out articles which were not related to the present study. When they both judged an article suitable for inclusion or when they could not decide whether or not an article met the inclusion criteria, the full text was obtained for further screening. Reference lists of the selected full text articles were reviewed to identify other articles that may be suitable for inclusion, and the full text of these articles were also downloaded. The two authors then individually read the full texts and decided the final selection of articles based on the pre-determined inclusion and exclusion criteria. If the two authors disagreed about an article, they discussed it together to make a final decision.

2.2. Inclusion and exclusion criteria {#s7b}
=====================================

The inclusion criteria were as follows: a) cross-sectional research related to RNFL thickness in individuals with AD or MCI; b) provides mean (sd) values for peripheral RNFL thickness; c) uses internationally recognized criteria for diagnosing AD and MCI, such as the criteria established by the National Institute of Neurologic and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDSADRDA),\[[@B19]\] the Diagnostic and Statistical Manual of Mental Disorders (DSM),\[[@B20]\] the Petersen criteria,\[[@B21]\] and so forth; and d) published in English or Chinese.

The exclusion criteria were as follows: a) articles that were not related to humans, b) systematic reviews, c) case reports, and d) duplicate reports.

2.3. Data acquisition and evaluation {#s7c}
====================================

Two authors (MW and ZS) individually gathered and evaluated the data. The results are shown in Tables 1 and 2. Recorded information included: name of the first author, publication date, location of the research, sample size, age, type of condition considered (AD or MCI), diagnostic criteria used, mini-mental state examination (MMSE) score, RNFL thicknesses (including total, and superior, inferior, nasal and temporal quadrant RNFL thicknesses), measurement methods for RNFL thickness, and the eyes tested (single or both).

Two authors (MW and ZS) independently assessed the quality of the included studies using the Newcastle- Ottawa Scale (NOS).\[[@B22]\] The scale has 8 items that are sub-divided into 3 dimensions: selection of case and control groups, comparability of case and control groups, and confirmation of exposure. The scale's overall score ranges from 0-9. The inter-rater reliability of the two raters' independent assessments of study quality was excellent (intraclass correlation coefficient \[ICC\]=0.96).

2.4. Statistical analysis {#s7d}
=========================

We built a database and analyzed the data using RevMan 5.3. Extraction of the data in each study about RNFL thickness included means (weighted mean difference, \[WMD\]) and standard deviations (95% confidence intervals, 95% CI). When *I*^2^≤50% and *p*\>0.10 (*I*^2^ is the measure of the degree of heterogeneity between different studies), the included studies were considered homogeneous so a fixed effect model was used to assess the pooled results; when 50% \< *I*^2^ ≤75% and/or *p* \< 0.10, the included studies were considered heterogeneous so a random effects model was used to assess the pooled results; when *I*^2^\>75%, the included studies were considered highly heterogeneous so sensitivity analyses (i.e., sequentially removing studies with extreme results and studies that accounted for a disproportionately large part of the pooled sample) and subgroup analyses were conducted to investigate the source of the heterogeneity. If sensitivity analysis and subgroup analysis were unable to identify the cause of the heterogeneity (i.e., *I*^2^ remained \>75%), the unidentified heterogeneity indicated that it was not suitable to pool the results of the studies in a metaanalysis. Additionally, when the number of studies in a subgroup fell below 3, the results of the studies were not pooled. When there were 10 or more studies in a particular analysis, we applied a funnel plot to evaluate the possibility of publication bias.

3.. Results {#s8}
===========

3.1.. Characteristics of included studies {#s8a}
=========================================

As shown in[Figure 1](#Figure1){ref-type="fig"}, 22 of the 3749 non-duplicated studies identified in the electronic search met the inclusion and exclusion criteria. Of the included studies, 18 were published in English-language journals\[[@B9], [@B10], [@B11], [@B12], [@B14], [@B15], [@B16], [@B18], [@B25], [@B26], [@B27], [@B28], [@B29], [@B30], [@B31], [@B32], [@B33], [@B34]\] (of which 5 were conducted in China\[[@B12], [@B14], [@B25], [@B26], [@B27]\]) and 4 were published in Chinese language journals.\[[@B13], [@B17], [@B23], [@B24]\] Three pairs of studies (Shen\[[@B25]\] and Shi\[[@B26]\]; Min\[[@B24]\] and Lu\[[@B27]\]; and Deng\[[@B23]\] and Chen\[[@B13]\]) were based on the same databases, so only one of each pair was retained. Thus, there were 19 studies included in the analysis, all of which were cross-sectional studies. One of these studies was only available as an abstract;\[[@B28]\] we tried to contact the corresponding and first authors of the article to get a copy of the full text, but received no reply.

The characteristics of the 19 studies published between 2001 and 2015 are shown in [Table 1](#Table1){ref-type="table"} and the crude results used in the analyses are shown in [Table 2](#Table2){ref-type="table"}. The studies were conducted in nine countries: 6 were from China;\[[@B12], [@B13], [@B14], [@B17], [@B24], [@B25]\] 3 from Turkey;\[[@B9], [@B18], [@B29]\] 3 from Spain;\[[@B16], [@B30], [@B31]\] 2 from Italy;\[[@B10], [@B28]\] and 1 each from Singapore, \[[@B15]\] France, \[[@B32]\] Canada, \[[@B33]\] the United Kingdom, \[[@B34]\] and Israel.\[[@B11]\] The pooled sample size of the 19 studies was 1455 subjects, including 508 with AD, 299 with MCI, and 718 controls.

###### 

Table 1. Characteristics of studies included in the systematic review

Table 1

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  study                                                country                                                      type of cases: number of cases (number of males)   controls (males)   age of cases mean(sd)        age of controls mean(sd)   diagnostic criteria                 MMSE score in cases mean(sd)   method      eyes        NOS score
  ---------------------------------------------------- ------------------------------------------------------------ -------------------------------------------------- ------------------ ---------------------------- -------------------------- ----------------------------------- ------------------------------ ----------- ----------- -----------
  Kergoat 2001\[[@B33]\]                               Canada                                                       AD(mild-mod):30(NA)                                30(NA)             70.0(1.3)                    72.1(1.3)                  NINCDS-ADRDA,\                      21.6(1.0)                      NFA         monocular   5.0
                                                                                                                                                                                                                                                  DSM-IV                                                                                     

  Parisi 2001\[[@B10]\]                                Italy                                                        AD(mild):17(9)                                     14(NA)             70.4(6.1)                    matched                    NINCDS-ADRDA,\                      \-\--                          OCT         monocular   5.0
                                                                                                                                                                                                                                                  DSM-III                                                                                    

  Iseri 2006\[[@B29]\]                                 Turkey                                                       AD(mild-mod):14(6)                                 15(7)              70.1(9.7)                    65.1(9.8)                  NINCDS-ADRDA,\                      18.5(6.3)                      OCT         binocular   5.0
                                                                                                                                                                                                                                                  DSM-IV                                                                                     

  Berisha 2007\[[@B34]\]                               United Kingdom                                               AD(mild-mod):9(NA)                                 8(NA)              74.3(3.3)                    74.3(5.8)                  NINCDS-ADRDA,\                      23.8(5.1)                      OCT         binocular   6.0
                                                                                                                                                                                                                                                  DSM-IV                                                                                     

  Paquet 2007\[[@B32]\]                                France                                                       MCI:23(8)\                                         15(2)              MCI:78.7(6.2)\               75.5(5.1)                  NINCDS-ADRDA 22.6 \[range:20-25\]   OCT                            binocular   3.5         
                                                                                                                    AD(mild):14(5)\                                                       AD(mild):78.3(5.1)\                                                                                                                                
                                                                                                                    AD(mod-sev):12(6)                                                     AD(mod-sev):78.8(4.9)                                                                                                                              

  Chi 2010\[[@B12]\]                                   China                                                        AD(mild-mod):12(7)                                 17(10)             75.4(7.30)                   75.3(5.8)                  NINCDS-ADRDA,\                      21.4(5.0)                      OCT         monocular   7.0
                                                                                                                                                                                                                                                  DSM-IV                                                                                     

  Kesler 2011\[[@B11]\]                                Israel                                                       MCI:24(NA)\                                        24(NA)             MCI:71.0(10.0)\              70.9(9.2)                  DSM-IV,\                            MCI:28.1(2.1)\                 OCT         binocular   5.5
                                                                                                                    AD(mild-mod):30(NA)                                                   AD:73.7(9.9)                                            Petersen criteria                   AD:23.6(4.3)                                           

  Min 2012\[[@B24]\]                                   China                                                        MCI:12(NA)\                                        30(NA)             MCI:71.6(6.1)\               71.5(5.2)                  NINCDS-ADRDA,\                      ≤25                            OCT         binocular   7.0
                                                                                                                    AD(mild):10(NA)\                                                      AD(mild):71.7(7.6)\                                     Petersen criteria                                                                          
                                                                                                                    AD(mod):10(NA)\                                                       AD(mod):71.4(6.1)\                                                                                                                                 
                                                                                                                    AD(sev):7(NA)                                                         AD(sev):72.1(7.7)                                                                                                                                  

  Chen2013\[[@B13]\]                                   China                                                        AD(mild-mod):38(16)                                26(11)             73.1(8.5)                    70.2(9.8)                  NINCDS-ADRDA                        \<28                           OCT         binocular   7.0

  Kirbas 2013\[[@B9]\]                                 Turkey                                                       AD(mild-mod):40(22)                                40(20)             69.3(4.9)                    68.9(5.1)                  NINCDS-ADRDA                        18-25                          OCT         monocular   5.0

  Moreno- Ramos 2013\[[@B30]\]                         Spain                                                        AD(mild):10(6)                                     10(6)              73.0(6.5)                    70.2(5.5)                  NINCDS-ADRDA                        16.4(1.5)                      OCT         binocular   5.0

  Ascaso 2014\[[@B31]\]                                Spain                                                        MCI:21(NA) AD:18(NA)\                              41(21)             72.1(8.7)                    72.9(7.9)                  DSM-IV,\                            MCI+AD:19.3                    OCT         binocular   5.0
                                                                                                                    MCI+AD:21(NA)                                                                                                                 Winblad criteria                                                                           

  Ferrari 2014\[[@B28]\]                               Italy                                                        AD(mild-mod):53(20)                                23(11)             71.5(6.6)                    66.7(7.4)                  \-\--                               \-\--                          OCT         \-\--       \-\--

  Garcia- Martin 2014\[[@B16]\]                        Spain                                                        AD(mild):20(8)                                     28(9)              79.3(4.1)                    72.1(5.1)                  NINCDS-ADRDA,\                      23.7(3.3)                      OCT         monocular   6.0
                                                                                                                                                                                                                                                  DSM-IV                                                                                     

  Shen 2014\[[@B25]\]                                  China                                                        MCI:23(10)                                         52(31)             74.4(3.2)                    74.1(2.6)                  Petersen criteria                   22.2(1.5)                      OCT         binocular   8.0

  Zhu 2014\[[@B17]\]                                   China                                                        MCI:47(14) AD:10(5)                                167(53)            MCI:76.1(8.2) AD:79.6(8.6)   75.5(7.7)                  CDR,ADL,DSM-IV,Petersen criteria    \-\--                          OCT         \-\--       7.5

  Cheung 2015\[[@B15]\]                                Singapore                                                    MCI:41(13)\                                        123(67)            MCI:70.4(10.2)\              65.7(3.8)                  NINCDS-ADRDA, DSM-IV,\              \-\--                          OCT         monocular   7.0
                                                                                                                    AD:100(43)                                                            AD:73.5(6.23)                                           Petersen criteria                                                                          

  Gao 2015\[[@B14]\]                                   China                                                        MCI:26(16)\                                        20(14)             AD:74.7 MCI:73.5             71.95                      NINCDS-ADRDA,\                      AD:23.6\                       OCT         binocular   7.0
                                                                                                                    AD(mild-mod):25(11)                                                                                                           Petersen criteria                   MCI:28.1                                               

  Oktem 2015\[[@B18]\]                                 Turkey                                                       MCI:35(15)\                                        35(12)             MCI:74.1(6.3)\               70.2(8.0)                  DSM-IV,\                            AD:18\                         OCT         binocular   6.0
                                                                                                                    AD:35(14)                                                             AD:75.4(6.9)                                            Petersen criteria                   MCI:28                                                 

  MCI, mild cognitive impairment                       AD(mod-sev), moderate-to-severe Alzheimer's disease          NFA, Nerve Fiber Analyzer                                                                                                                                                                                                

  AD, Alzheimer's disease                              NINCDS-ADRDA, National Institute of Neurologic and           NOS, Newcastle-Ottawa Scale                                                                                                                                                                                              

  AD(mild), mild Alzheimer's disease                   Communicative Disorders and Stroke-Alzheimer\'s Disease      CDR, Clinical Dementia Rating                                                                                                                                                                                            

  AD(mod), moderate Alzheimer's disease                and Related Disorders Association                            ADL, Activities of Daily Living                                                                                                                                                                                          

  AD(sev), severe Alzheimer's disease                  DSM, Diagnostic and Statistical Manual of Mental Disorders   NA, not available                                                                                                                                                                                                        

  AD(mild-mod), mild-to-moderate Alzheimer's disease   MMSE, Mini-Mental Status Examination                         OCT, Optical Coherence Tomography                                                                                                                                                                                        
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Table.2 Total and four quadrant mean (sd) retinal nerve fiber layer (RNFL) thickness for normal controls (NC), individuals with Mild Cognitive Impairment (MCI), and individuals with Alzheimer\'s Disease (AD) in the studies included in each of the comparative analyses

Table 2

  groups compared/study          total        superior quadrant   inferior quadrant   nasal quadrant   temporal quadrant                                                        
  ------------------------------ ------------ ------------------- ------------------- ---------------- ------------------- ------------- ------------ ------------ ------------ ------------
  AD vs NC                       AD           NC                  AD                  NC               AD                  NC            AD           NC           AD           NC
  Kergoat 2001\[[@B33]\]         66.2(2.2)    62.0(2.5)           76.8(2.9)           69.9(2.8)        74.3(2.6)           70.7(3.2)     50.1(1.9)    49.4(2.3)    42.1(2.1)    39.4(2.0)
  Parisi 2001\[[@B10]\]          59.5(16.7)   99.9(9.0)           72.1(21.4)          104.6(12.1)      77.9(26.4)          116.2(9.9)    50.4(23.2)   93.4(13.7)   37.9(17.6)   85.6(8.2)
  Iseri 2006\[[@B29]\]           87.5(23.8)   113.2(6.7)          112.6(35.3)         137.2(16.5)      103.1(33.6)         141.6(19.1)   63.6(19.1)   96.0(34.4)   64.9(17.7)   72.3(16.4)
  Berisha 2007\[[@B34]\]         \-\--        \-\--               92.2(21.6)          113.6(10.8)      117.0(15.3)         128.1(11.4)   65.7(15.1)   64.1(7.3)    67.0(15.0)   69.5(11.1)
  Paquet 2007\[[@B32]\]          89.2(2.9)    102.2(1.8)          \-\--               \-\--            \-\--               \-\--         \-\--        \-\--        \-\--        \-\--
  Chi2010\[[@B12]\]              93.2(11.3)   99.4(8.9)           115.1(14.1)         127.9(12.3)      120.6(18.0)         129.6(15.2)   65.8(13.0)   65.3(9.0)    72.4(17.9)   74.7(11.7)
  Kesler 2011\[[@B11]\]          84.7(10.6)   94.3(11.3)          99.0(18.0)          110.0(16.7)      110.1(19.1)         127.0(15.5)   66.8(14.5)   76.4(21.8)   61.7(10.9)   67.8(15.1)
  Min 2012\[[@B24]\]             93.7(6.1)    103.0(10.1)         119.1(15.1)         125.2(19.3)      123.0(9.7)          131.1(12.7)   73.7(17.3)   79.2(21.1)   62.2(15.0)   70.2(14.2)
  Chen2013\[[@B13]\]             95.4(29.5)   105.9(29.9)         116.8(16.5)         131.7(13.9)      121.6(18.7)         133.3(9.9)    71.9(20.9)   79.0(12.8)   71.3(12.3)   79.6(16.5)
  Kirbas 2013\[[@B9]\]           65(6.2)      75(3.8)             76(6.7)             105(4.8)         106(11.5)           108(8.7)      75(2.8)      76(2.7)      74(6.7)      77(7.3)
  Moreno-Ramos 2013\[[@B30]\]    94.5(2.2)    108.0(2.2)          \-\--               \-\--            \-\--               \-\--         \-\--        \-\--        \-\--        \-\--
  Ascaso 2014\[[@B31]\]          64.8(15.2)   103.6(8.9)          73.2(22.0)          126.6(13.8)      86.2(25.7)          135.6(17.6)   43.3(20.4)   77.8(16.7)   56.7(14.9)   75.8(16.6)
  Ferrari 2014\[[@B28]\]         92.1(9.8)    98.2(5.9)           112.5(17.3)         121.4(12.5)      119.0(16.5)         125.9(10.0)   69.5(12.2)   74.0(12.7)   67.3(12.0)   71.4(12.2)
  Garcia-Martin 2014\[[@B16]\]   \-\--        \-\--               101.4(16.5)         102.2(10.8)      110.8(11.1)         111.8(10.8)   70.5(12.8)   72.3(10.6)   71.8(12.5)   70.6(11.6)
  Zhu2014\[[@B17]\]              90.7(15.8)   96.7(9.6)           110.9(27.4)         125.2(20.6)      122.1(19.9)         131.4(20.1)   67.9(9.2)    67.1(14.0)   62.1(19.5)   84.3(13.8)
  Cheung2015\[[@B15]\]           86.8(1.4)    90.4(1.7)           105.7(2.3)          113.5(2.8)       108.2(2.6)          114.3(3.1)    68.5(1.6)    68.1(1.9)    64.9(1.9)    65.3(2.2)
  Gao2015\[[@B14]\]              86.2(10.0)   97.6(6.2)           106.5(19.1)         121.1(11.8)      108.7(16.8)         126.1(10.3)   66.5(10.3)   69.3(7.9)    63.4(11.7)   74.0(11.5)
  Oktem2015\[[@B18]\]            80.6(9.6)    91.5(7.1)           \-\--               \-\--            \-\--               \-\--         \-\--        \-\--        \-\--        \-\--
  Paquet 2007\[[@B32]\]          89.3(2.7)    102.2(1.8)          \-\--               \-\--            \-\--               \-\--         \-\--        \-\--        \-\--        \-\--
  Kesler 2011\[[@B11]\]          85.8(10.0)   94.3(11.3)          101.3(15.2)         110.0(16.7)      111.9(16.1)         127.0(15.5)   65.9(15.1)   76.4(21.8)   64.2(13.9)   67.8(15.1)
  Min 2012\[[@B24]\]             99.1(11.3)   103.0(10.1)         123.1(13.1)         125.2(19.3)      129.2(12.7)         131.1(12.7)   75.6(21.7)   79.2(21.1)   70.3(11.2)   70.2(14.2)
  Ascaso 2014\[[@B31]\]          86.0(7.3)    103.6(8.9)          96.7(14.6)          126.6(13.8)      110.1(17.7)         135.6(17.6)   71.0(16.8)   77.8(16.7)   66.3(12.1)   75.8(16.6)
  Shen 2014\[[@B25]\]            82.6(10.5)   85.6(10.2)          101.8(16.8)         104.7(15.4)      104.5(17.6)         109.3(21.3)   61.5(8.1)    64.8(8.4)    62.7(12.2)   65.5(10.1)
  Zhu 2014\[[@B17]\]             96.8(9.9)    96.7(9.6)           117.1(18.3)         125.2(20.6)      128.7(17.2)         131.4(20.1)   67.6(12.2)   67.1(14.0)   73.1(13.5)   84.3(13.8)
  Cheung 2015\[[@B15]\]          89.2(1.8)    90.4(1.7)           110.9(2.9)          113.5(2.8)       112.2(3.2)          114.3(3.1)    68.9(2.0)    68.1(1.9)    65.1(2.30)   65.3(2.2)
  Gao 2015\[[@B14]\]             93.7(11.2)   97.6(6.2)           112.9(19.3)         121.1(11.8)      125.4(18.7)         126.1(10.3)   68.8(9.5)    69.3(7.9)    66.6(12.8)   74.0(11.5)
  Oktem 2015\[[@B18]\]           82.5(7.3)    91.5(7.1)           \-\--               \-\--            \-\--               \-\--         \-\--        \-\--        \-\--        \-\--
  AD vs MCI                      AD           MCI                 AD                  MCI              AD                  MCI           AD           MCI          AD           MCI
  Paquet 2007\[[@B32]\]          89.2(2.9)    89.3(2.7)           \-\--               \-\--            \-\--               \-\--         \-\--        \-\--        \-\--        \-\--
  Kesler 2011\[[@B11]\]          84.7(10.6)   85.8(10.0)          99.0(18.0)          101.3(15.2)      110.1(19.1)         111.9(16.1)   66.8(14.5)   65.9(15.1)   61.7(10.9)   64.2(13.9)
  Min 2012\[[@B24]\]             93.7(6.1)    99.1(11.3)          119.1(15.1)         123.1(13.1)      123.0(9.7)          129.2(12.7)   73.7(17.3)   75.6(21.7)   62.2(15.0)   70.3(11.2)
  Ascaso 2014\[[@B31]\]          64.8(15.2)   86.0(7.3)           73.2(22.0)          96.7(14.6)       86.2(25.7)          110.1(17.7)   43.3(20.4)   71.0(16.8)   56.7(14.9)   66.3(12.1)
  Zhu 2014\[[@B17]\]             90.7(15.8)   96.8(9.9            110.9(27.4)         117.1(18.3)      122.1(19.9)         128.7(17.2)   67.9(9.2)    67.6(12.2)   62.1(19.5)   73.1(13.5)
  Cheung 2015\[[@B15]\]          86.8(1.4)    89.21(1.8)          105.7(2.3)          110.9(2.9)       108.2(2.6)          112.2(3.2)    68.5(1.6)    68.9(2.0)    64.9(1.9)    65.1(2.3)
  Gao 2015\[[@B14]\]             86.2(10.0)   93.7(11.2)          106.5(19.1)         112.9(19.3)      108.7(16.8)         125.4(18.7)   66.5(10.3)   68.8(9.5)    63.4(11.7)   66.7(12.8)
  Oktem 2015\[[@B18]\]           80.6(9.6)    82.5(7.3)           \-\--               \-\--            \-\--               \-\--         \-\--        \-\--        \-\--        \-\--

Twelve of the 19 studies included individuals with mild or moderate AD.\[[@B9], [@B10], [@B11], [@B12], [@B13], [@B14], [@B24], [@B29], [@B30], [@B32], [@B33], [@B34]\] Four did not specify the severity of disease, \[[@B15], [@B17], [@B18], [@B31]\] and 4 did not provide MMSE scores of individuals with AD.\[[@B10], [@B15], [@B17], [@B28]\] One study classified AD as 'mild', 'moderate' and 'severe', \[[@B24]\] and one classified AD as 'mild' and 'moderate or severe';\[[@B32]\] to minimize heterogeneity in the results of the included studies, we only extracted the data of individuals with mild AD from these 2 studies. Fourteen studies provided data of peripheral RNFL thickness (including the total, superior, inferior, nasal and temporal quadrant RNFL thicknesses);\[[@B9], [@B10], [@B11], [@B12], [@B13], [@B14], [@B15], [@B17], [@B24], [@B25], [@B28], [@B29], [@B31], [@B33]\] two studies only provided data on the RNFL thickness of the 4 optical nerve quadrants;\[[@B16], [@B34]\] and 3 studies only provided data on total RNFL.\[[@B18], [@B30], [@B32]\] We tried to contact the corresponding authors of these studies; only one author replied, \[[@B18]\] indicating that the study had not gathered data about RNFL thickness in each quadrant.

Apart from one study which was only available in abstract and did not provide the AD and MCI diagnostic criteria, \[[@B28]\] other studies diagnosed individuals with AD by use of the NINCDS-ADRDA guidelines or DSM criteria. Most studies involving individuals with MCI diagnosed individuals with MCI using the Petersen criteria; one used Winbald criteria;\[[@B31]\] and one based the MCI diagnosis on memory complaints, and scores in the delayed memory test of the MMSE.\[[@B32]\]

Aside from 1 study which used NFA to measure RNFL thickness, \[[@B33]\] the other studies all used OCT. Six of the studies only measured a single eye;\[[@B9], [@B10], [@B12], [@B15], [@B16], [@B33]\] 11 studies measured both eyes and reported the mean RNFL thickness of both eyes;\[[@B11], [@B13], [@B14], [@B18], [@B24], [@B25], [@B29], [@B30], [@B31], [@B32], [@B34]\] 1 study provided separate measures of the RNFL thickness in the right and left eyes (the results were similar, so we used the data for the right eye);\[[@B31]\] and 2 studies did not mention whether a single eye or both eyes had been assessed.\[[@B17], [@B28]\]

Eighteen studies found that RNFL thicknesses among individuals with AD or MCI were significantly thinner than that in the controls; the remaining study showed inconsistent results.\[[@B33]\] Some studies that compared RNFL thickness in each quadrant of the optic nerve between different groups of individuals reported that the RNFL thicknesses of individuals with AD or MCI were significantly thinner than that in controls in the superior\[[@B9], [@B12], [@B13], [@B14], [@B15], [@B17], [@B34]\] and inferior quadrants;\[[@B11], [@B14], [@B25]\] while other studies found significant differences in the temporal quadrant.\[[@B14], [@B16], [@B17]\] Comparing RNFL thickness in individuals with AD versus that in individuals with MCI, 3 studies found that the RNFL thickness among individuals with AD was significantly thinner than that among individuals with MCI, \[[@B14], [@B31], [@B32]\] and 4 studies showed thinner RNFL in AD than in MCI, but the difference was not statistically significant.\[[@B11], [@B15], [@B18], [@B25]\]

3.2. Quality assessments and publication bias of included studies {#s8b}
=================================================================

We used the NOS scale to assess the quality of the included studies. One study was only an abstract, so we did the quality assessments on 18 studies. The mean ratings of the two independent raters are shown in Table 1. The overall score ranged from 4 to 8 (the theoretical range is 0 to 9), and the mean (sd) score was 5.66 (1.79). The NOS scale does not have a standard cutoff score for 'high-quality' studies, so we chose to classify studies with NOS scores of 7 or higher as 'high-quality'. Based on this cutoff score, 7 of the 18 studies (39%) were classified as 'high-quality'; 6 of these 7 high-quality studies were conducted in China. The main reasons studies were rated as 'low-quality' included using other psychiatric inpatients as controls and not using blinded evaluation of the RNFL assessment. In the absence of additional information, the study for which we only had an abstract\[[@B28]\] was also classified as 'low-quality'.

We analyzed the possibility of publication bias among the 17 studies which compared total RNFL thickness between individuals with AD or MCI and normal controls. As shown in [Figure 2](#Figure2){ref-type="fig"}, the funnel plot depicted an obvious asymmetry, indicating publication bias with smaller studies showing a greater mean difference in RNFL thickness between normal controls and those with AD or MCI.

![Figure 2. Funnel plot of publication bias in comparison of mean total retinal nerve fiber layer (RNFL) thickness between cases and controls for 17 studies](sap-27-05-263-e002){#Figure2}

3.3. Differences between the RNFL thickness among individuals with Alzheimer's disease and normal controls {#s8c}
==========================================================================================================

The heterogeneity test for the 16 studies that compared the total RNFL thickness of individuals with AD to that of normal controls\[[@B9], [@B10], [@B11], [@B12], [@B13], [@B14], [@B15], [@B17], [@B18], [@B24], [@B28], [@B29], [@B30], [@B31], [@B32], [@B33]\] indicated high heterogeneity (*I*^2^=97%), and sensitivity analysis (i.e., removing studies with extreme results and those that accounted for a disproportionately large part of the pooled sample) did not find the source of heterogeneity, so we used subgroup analysis to further explore the source of heterogeneity. We classified studies based on quality: high-quality group had NOS scores ≥ 7; lowquality group had NOS scores \< 7. As shown in [Figure 3](#Figure3){ref-type="fig"}A, the 6 high-quality studies had improved homogeneity for total RNFL thickness (*I*^2^=70%), but the 10 low-quality studies remained quite heterogeneous (*I*^2^=98%). Meta-analysis using a random effects model of the pooled sample of 578 subjects from the 6 high-quality studies found a weighted mean difference (WMD) of -7.34 (95% CI, -11.29 to -3.40; *p* \< 0.001). Thus, when only considering the methodologically stronger studies, the total RNFL thickness of individuals with AD was significantly thinner than that of normal controls.

![Figure 3. Comparison of retinal nerve fiber layer (RNFL) thickness in individuals with Alzheimer's disease (AD) versus normal controls (NC) stratified by study quality](sap-27-05-263-e003){#Figure3}

Heterogeneity tests for the 15 studies that compared RNFL thicknesses in each of the four quadrants of the optic nerve of individuals with AD to normal controls\[[@B9], [@B10], [@B11], [@B12], [@B13], [@B14], [@B15], [@B16], [@B17], [@B24], [@B28], [@B29], [@B31], [@B33], [@B34]\] found *I*^2^ values ranging from 87% to 98%, indicating high heterogeneity between the studies. As was true for the total RNFL thickness, sensitivity analysis did not identify the source of the heterogeneity, but subclassification of the studies into 6 high-quality studies and 9 low-quality studies found that the homogeneity was sufficient to justify pooling results of the 6 high-quality studies for the RNFL thickness in superior (*I*^2^=30%), inferior (*I*^2^=53%), and nasal (*I*^2^=7%) quadrants, but the high heterogeneity of the high-quality study results for the temporal quadrant (*I*^2^=82%) precluded conducting a meta-analysis. Results for the 9 low-quality studies indicate high heterogeneity of RNFL thickness for all four quadrants (*I*^2^\>75%), so it was not possible to pool the results in meta-analyses. Meta-analysis using fixed effect models in the pooled sample of 578 in the 6 high-quality studies found a WMD of -7.92 (95% CI, -8.58 to -7.26, *p* \< 0.001) for the superior quadrant ([Figure 3](#Figure3){ref-type="fig"}B) and a WMD of 0.03 (95% CI, -1.28 to 1.34, *p*=0.960) for the nasal quadrant; meta-analysis using a random effects model in these 6 studies found a WMD of -9.53 (95% CI, -13.51 to -5.5, *p* \< 0.001) for the inferior quadrant ([Figure 3](#Figure3){ref-type="fig"}C). Thus, based on results from the high-quality studies, the RNFL thickness in the superior and inferior quadrants of the occipital nerve was significantly thinner in individuals with AD than in normal controls, but this was not the case in the nasal or temporal quadrants.

3.4. Differences between the retinal nerve fiber layer thickness of individuals with MCI and normal controls {#s8d}
============================================================================================================

Heterogeneity tests of the results for the 9 studies that compared total RNFL thickness between individuals with MCI and normal controls\[[@B11], [@B14], [@B15], [@B17], [@B18], [@B24], [@B25], [@B31], [@B32]\] showed high heterogeneity (*I*^2^=97%). Sensitivity analysis did not find the source of heterogeneity, but subgroup analysis found that the 5 high-quality studies were sufficiently homogenous (*I*^2^=0%) to justify pooling the results using a fixed effect model while the 4 low-quality studies were sufficiently homogeneous (*I*^2^=75%) to justify pooling the results using a random effects model. Meta-analysis of the pooled sample of 541 individuals from the 5 high-quality studies using a fixed effect model found a WMD of -1.20 (95% CI, -1.79 to -0.60, *p* \< 0.001), and meta-analysis of the pooled sample of 218 individuals from the 4 low-quality studies using a random effects model found a WMD of -12.22 (95% CI, -15.56 to -8.88) ([Figure 4](#Figure4){ref-type="fig"}A). This indicates that total RNFL thickness in individuals with MCI was significantly thinner than that in normal controls.

![Figure 4. Comparison of retinal nerve fiber layer (RNFL) thickness in individuals with mild cognitive impairment (MCI) versus normal controls (NC)](sap-27-05-263-e004){#Figure4}

Heterogeneity tests for the 7 studies which provided the data about RNFL thickness in each quadrant, \[[@B11], [@B14], [@B15], [@B17], [@B24], [@B25], [@B31]\] indicated high heterogeneity of the results for the superior, inferior, and temporal quadrants (*I*^2^\>75%). Sensitivity analysis found that after removing the study by Ascaso, \[[@B31]\] the *I*^2^ value for the superior quadrant results dropped from 89% to 17% and that for the inferior quadrant dropped from 81% to 41%, indicating that the low-quality study by Ascaso\[[@B31]\] (which, based on MMSE scores, included individuals with relatively severe AD) was the reason for the heterogeneity of the 7 studies in these two quadrants. Meta-analysis of the pooled sample of 589 subjects in the remaining 6 studies using a fixed effect model found a WMD of -2.87 (95% CI, -3.84 to -1.91, *p* \< 0.001) for the superior quadrant ([Figure 4](#Figure4){ref-type="fig"}B), and a WMD of -2.31 (95% CI, -3.37 to -1.25, *p* \< 0.001) for the inferior quadrant ([Figure 4](#Figure4){ref-type="fig"}C), indicating that, based on the subset of studies that excludes the study by Ascaso, \[[@B31]\] the RNFL thickness in the superior and inferior quadrants of the optic nerve of individuals with MCI were significantly thinner than those in normal controls.

We also did sensitivity analysis for the RNFL results for the temporal quadrant and found that after removing Cheung's study\[[@B15]\] *I*^2^ declined from 82% to 48%, suggesting that this study was the reason for the high heterogeneity. As shown in [Figure 4](#Figure4){ref-type="fig"}D, meta-analysis of the pooled sample of 487 individuals in the remaining 6 studies using a fixed effect model found a WMD of -6.92 (95% CI, -9.48 to -4.35, *p* \< 0.001), indicating that, based on the subset of studies that excludes the study by Cheung, \[[@B15]\] the RNFL thickness in the temporal quadrant of the optic nerve among individuals with MCI was significantly thinner than that in normal controls.

Heterogeneity tests for the results for the nasal quadrant in the 7 studies that compared individuals with MCI to normal controls found an *I*^2^ of 48%; meta-analysis of the pooled sample of 651 individuals in the 7 studies using a fixed effect model found a WMD of 0.59 (95% CI, -0.07 to 1.25, *p*=0.080), indicating no significant difference in the thickness of the nasal quadrant of the optic nerve in individuals with MCI compared to that in normal controls.

3.5. The differences between the retinal nerve fiber layer thickness of individuals with AD and individuals with MCI {#s8e}
====================================================================================================================

Heterogeneity testing for the 8 studies that compared total RNFL thickness in individuals with AD versus that in individuals with MCI, \[[@B11], [@B14], [@B15], [@B17], [@B18], [@B24], [@B31], [@B32]\] found high heterogeneity (*I*^2^=79%). The *I*^2^ declined substantially (to 40%) after removing Ascaso's study\[[@B31]\] in the sensitivity analysis. As shown in [Figure 5](#Figure5){ref-type="fig"}A, meta-analysis of the pooled sample of 432 individuals in the remaining 7 studies using a fixed effect model found a SMD of -2.23 (95% CI, -2.79 to -1.67, *p* \< 0.001), indicating that, based on the subset of studies that excludes the study by Ascaso, \[[@B31]\] the total RNFL thickness in individuals with AD was significantly thinner than that in individuals with MCI.

![Figure 5. Comparison of retinal nerve fiber layer (RNFL) thickness in individuals with Alzheimer's disease (AD) versus mild cognitive impairment (MCI)](sap-27-05-263-e005){#Figure5}

Assessment of the heterogeneity testing of the 6 studies which provided data for RNFL thickness in each quadrant\[[@B11], [@B14], [@B15], [@B17], [@B24], [@B31]\] found that *I*^2^ in the superior quadrant was 47%; meta-analysis of the pooled sample of 364 subjects in the 6 studies using a fixed effect model found a SMD of -5.29 (95% CI, -6.26 to -4.32, *p* \< 0.001) ([Figure 5](#Figure5){ref-type="fig"}B), indicating significantly thinner RNFL in the superior quadrant of the optic nerve of individuals with AD versus that in individuals with MCI. The *I*^2^ for the results of the 6 studies for the inferior quadrant was 66%; meta-analysis of the pooled sample of 364 subjects using a random effects model ([Figure 5](#Figure5){ref-type="fig"}C) found a WMD of -8.44 (95% CI, -14.18 to -2.70, *p*=0.004), indicating that the inferior quadrant of the optic nerve in individuals with AD is also significantly thinner than that in individuals with MCI.

The *I*^2^ for the results of the 6 studies for the temporal quadrant of the optic nerve was 50%. Metaanalysis of the pooled sample of 364 subjects using a fixed effect model found a WMD of -0.43 (95% CI, -1.21 to 0.34, *p*=0.270), indicating no significant difference in the thickness of the temporal quadrant of the optic nerve between individuals with AD and those with MCI.

The *I*^2^ for the results in the 6 studies for the nasal quadrant was 76%; a sensitivity analysis indicated that the study by Ascaso\[[@B31]\] was the cause of the high heterogeneity. After deleting this study, the *I*^2^ dropped to 0% and a meta-analysis of the pooled sample of 325 subjects in the 5 remaining studies using a fixed effect model found a WMD of -0.40 (95% CI, -1.07 to 0.26, *p*=0.230), indicating that, based on the subset of studies that excludes the study by Ascaso, \[[@B31]\] the thickness of the nasal quadrant of the optic nerve in persons with AD is not significantly different from that of persons with MCI.

4.. Discussion {#s9}
==============

4.1. Main findings {#s9a}
==================

Assessing RNFL thickness using the Optical Coherence Tomography (OCT) technology is safe, quick, and relatively accurate, so there is a substantial and growing literature about the potential power of the method to predict the onset of MCI and AD. We found 19 studies, including 6 from China (4 of which had only been published in Chinese), that assess total RNFL thickness and RNFL thickness in the 4 quadrants of the optic nerve in AD or MCI. Most of the studies had relatively small sample sizes, the severity of MCI and AD varied considerably across studies, and only a minority of the studies were methodologically robust, so it is not surprising that the results were quite heterogeneous. When restricting the analysis to 6 high-quality studies (5 were conducted in China and 1 in Singapore), the meta-analysis of the pooled sample indicated that the total RNFL thickness and that in the superior and inferior quadrants of the visual nerve were significantly thinner in individuals with AD than in matched healthy controls. Similarly, pooling results from 5 high-quality studies that compared RNFL results for MCI and controls, indicated significantly thinner total RNFL in MCI than in controls, and pooling results from studies that provided quadrant-specific results showed significantly thinner RNFL in the superior, inferior, and temporal quadrants of individuals with MCI versus that in normal controls. Results from studies that directly compared RNFL thickness in individuals with mild or moderate AD to that in individuals with MCI found (after removing one outlier study) that RNFL thickness was significantly thinner in individuals with AD than in individuals with MCI. Thus, there appears to be a progressive thinning of the RNFL as cognitive functioning declines. This finding confirms several community-based studies that report that RNFL becomes thinner with age\[[@B35], [@B36], [@B37]\] and as cognitive function declines.\[[@B38], [@B39], [@B40]\] These changes are most evident in the superior and inferior quadrants of the optic nerve, but there does not appear to be any quadrant-specific results, so there is no clear advantage to using quadrant-specific measures of RNFL thickness instead of the measure for total RNFL thickness.

4.2. Limitations {#s9b}
================

This analysis has had four major limitations. First, the sample sizes of the included studies were generally small; only 2 of the 19 studies\[[@B15], [@B17]\] had more than 100 subjects. This meant that the pooled samples used in the different meta-analyses were also relatively small. Second, the overall research quality was low; only 7 of the 19 studies were judged to be 'high-quality'. Third, potential confounders such as age, gender, smoking history, blood pressure, blood sugar, blood lipids, and so forth, were not considered. All of the studies were cross-sectional, so there was no opportunity to demonstrate progressive thinning of RNFL with cognitive decline. Finally, there was a clear publication bias in the included studies (with smaller studies favoring larger differences between cases and controls) and several of the included studies did not have blind raters assess the RNFL (increasing the risk of performance bias).

4.3. Importance {#s9c}
===============

Abnormality in retinal tissues is closely related to pathological changes of the central nervous system so neurodegenerative diseases such as AD should be reflected in changes in the optic nerve. This systematic review and meta-analysis included 19 studies (4 of which were only available in Chinese) that compared peripheral RNFL thickness of individuals with AD, MCI, and age and gender matched normal controls. The results show that RNFL thickness - primarily the total thickness and that in the superior and inferior quadrants of the visual nerve - was significantly thinner in individuals with MCI than in normal controls and significantly thinner in individuals with AD than in individuals with MCI. This progressive thinning as the severity of cognitive decline increases suggests that RNFL thickness could be used as marker for the detection of early AD. The lack of unique findings by quadrant of the visual nerve suggests that the total RNFL score is sufficient; reporting RNFL results by quadrant does not increase the predictive power of the information.
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